These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35541758)

  • 41. Potent inhibitors of malarial aspartic proteases, the plasmepsins, by hydroformylation of substituted 7-azanorbornenes.
    Aureggi V; Ehmke V; Wieland J; Schweizer WB; Bernet B; Bur D; Meyer S; Rottmann M; Freymond C; Brun R; Breit B; Diederich F
    Chemistry; 2013 Jan; 19(1):155-64. PubMed ID: 23161835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plerixafor and related macrocyclic amines are potential drug candidates in treatment of malaria by "filling the flap" region of plasmepsin enzymes.
    Abiri A
    Med Hypotheses; 2018 Sep; 118():68-73. PubMed ID: 30037618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computational analysis of plasmepsin IV bound to an allophenylnorstatine inhibitor.
    Gutiérrez-de-Terán H; Nervall M; Dunn BM; Clemente JC; Aqvist J
    FEBS Lett; 2006 Oct; 580(25):5910-6. PubMed ID: 17045991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fragment-Based Discovery of 2-Aminoquinazolin-4(3H)-ones As Novel Class Nonpeptidomimetic Inhibitors of the Plasmepsins I, II, and IV.
    Rasina D; Otikovs M; Leitans J; Recacha R; Borysov OV; Kanepe-Lapsa I; Domraceva I; Pantelejevs T; Tars K; Blackman MJ; Jaudzems K; Jirgensons A
    J Med Chem; 2016 Jan; 59(1):374-87. PubMed ID: 26670264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
    Moura PA; Dame JB; Fidock DA
    Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural dynamics of Casein Kinase I (CKI) from malarial parasite Plasmodium falciparum (Isolate 3D7): Insights from theoretical modelling and molecular simulations.
    Dehury B; Behera SK; Mahapatra N
    J Mol Graph Model; 2017 Jan; 71():154-166. PubMed ID: 27923179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aspartic proteases from Plasmodium chabaudi: a rodent model for human malaria.
    Martins TM; Novo C; do Rosário VE; Domingos A
    Acta Trop; 2003 Dec; 89(1):1-12. PubMed ID: 14636976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pepsin-like aspartic proteases (PAPs) as model systems for combining biomolecular simulation with biophysical experiments.
    Bhakat S
    RSC Adv; 2021 Mar; 11(18):11026-11047. PubMed ID: 35423571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Computational perspectives into plasmepsins structure-function relationship: implications to inhibitors design.
    Gil L A; Valiente PA; Pascutti PG; Pons T
    J Trop Med; 2011; 2011():657483. PubMed ID: 21760810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
    Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
    J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enzymatic Characterization of Recombinant Food Vacuole Plasmepsin 4 from the Rodent Malaria Parasite Plasmodium berghei.
    Liu P; Robbins AH; Marzahn MR; McClung SH; Yowell CA; Stevens SM; Dame JB; Dunn BM
    PLoS One; 2015; 10(10):e0141758. PubMed ID: 26510189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design and synthesis of potent inhibitors of plasmepsin I and II: X-ray crystal structure of inhibitor in complex with plasmepsin II.
    Johansson PO; Lindberg J; Blackman MJ; Kvarnström I; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    J Med Chem; 2005 Jun; 48(13):4400-9. PubMed ID: 15974592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New organofluorine building blocks: inhibition of the malarial aspartic proteases plasmepsin II and IV by alicyclic alpha,alpha-difluoroketone hydrates.
    Fäh C; Hardegger LA; Baitsch L; Schweizer WB; Meyer S; Bur D; Diederich F
    Org Biomol Chem; 2009 Oct; 7(19):3947-57. PubMed ID: 19763297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploring Aspartic Protease Inhibitor Binding to Design Selective Antimalarials.
    Bobrovs R; Basens EE; Drunka L; Kanepe I; Matisone S; Velins KK; Andrianov V; Leitis G; Zelencova-Gopejenko D; Rasina D; Jirgensons A; Jaudzems K
    J Chem Inf Model; 2022 Jul; 62(13):3263-3273. PubMed ID: 35712895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.
    Gambini L; Rizzi L; Pedretti A; Taglialatela-Scafati O; Carucci M; Pancotti A; Galli C; Read M; Giurisato E; Romeo S; Russo I
    PLoS One; 2015; 10(11):e0142509. PubMed ID: 26566224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural insights into the activation of P. vivax plasmepsin.
    Bernstein NK; Cherney MM; Yowell CA; Dame JB; James MN
    J Mol Biol; 2003 Jun; 329(3):505-24. PubMed ID: 12767832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression and characterisation of plasmepsin I from Plasmodium falciparum.
    Moon RP; Tyas L; Certa U; Rupp K; Bur D; Jacquet C; Matile H; Loetscher H; Grueninger-Leitch F; Kay J; Dunn BM; Berry C; Ridley RG
    Eur J Biochem; 1997 Mar; 244(2):552-60. PubMed ID: 9119023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasmodium falciparum, P. vivax, and P. malariae: a comparison of the active site properties of plasmepsins cloned and expressed from three different species of the malaria parasite.
    Westling J; Yowell CA; Majer P; Erickson JW; Dame JB; Dunn BM
    Exp Parasitol; 1997 Nov; 87(3):185-93. PubMed ID: 9371083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetic analysis of plasmepsins I and II aspartic proteases of the Plasmodium falciparum digestive vacuole.
    Luker KE; Francis SE; Gluzman IY; Goldberg DE
    Mol Biochem Parasitol; 1996 Jul; 79(1):71-8. PubMed ID: 8844673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New class of small nonpeptidyl compounds blocks Plasmodium falciparum development in vitro by inhibiting plasmepsins.
    Jiang S; Prigge ST; Wei L; Gao Ye ; Hudson TH; Gerena L; Dame JB; Kyle DE
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2577-84. PubMed ID: 11502532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.